Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript May 6, 2025
Standard BioTools Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.04.
John Graziano – VP of IR:
Michael Egholm – President & CEO:
Alex Kim – CFO:
Operator: Good day and welcome to the Standard BioTools, Inc., First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over...
